InvestSMART

Imugene Limited (ASX: IMU) - Announcements

Current share price for IMU : $0.032 0.001 (3.23%)+

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$18 Change of Director's Interest Notice x2 - KD & JD 20 Nov 2026 4:03PM $0.031 $0.032 risen by 3.23%
$18 Application for quotation of securities - IMU 20 Nov 2026 3:58PM $0.031 $0.032 risen by 3.23%
$18 Final Director's Interest Notice - LR 18 Nov 2026 4:08PM $0.032 $0.032 fallen by 0%
$18 Notification of cessation of securities - IMU 18 Nov 2026 4:03PM $0.032 $0.032 fallen by 0%
$18 Imugene Receives $2.1M R&D Tax Refund 16 Nov 2026 9:04AM $0.036 $0.032 fallen by 11.11%
$18 Director Resignation and Committee Changes 11 Nov 2026 2:02PM $0.035 $0.032 fallen by 8.57%
$18 Results of 2026 Annual General Meeting 11 Nov 2026 12:22PM $0.035 $0.032 fallen by 8.57%
$18 AGM Presentation 11 Nov 2026 8:50AM $0.036 $0.032 fallen by 11.11%
$18 Imugene selected for Poster Presentation at 2026 ASH Meeting 5 Nov 2026 3:27PM $0.035 $0.032 fallen by 8.57%
$18 Positive amendments to Convertible Notes 3 Nov 2026 9:47AM $0.034 $0.032 fallen by 5.88%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 9:43AM $0.038 $0.032 fallen by 15.79%
$18 Further Responses in azer-cel Phase 1b Trial 19 Oct 2026 9:38AM $0.036 $0.032 fallen by 11.11%
$18 Notification of cessation of securities - IMU 16 Oct 2026 4:15PM $0.036 $0.032 fallen by 11.11%
$18 Application for quotation of securities - IMU 15 Oct 2026 9:48AM $0.036 $0.032 fallen by 11.11%
$18 Application for quotation of securities - IMU 14 Oct 2026 2:56PM $0.036 $0.032 fallen by 11.11%
$18 Notice of Annual General Meeting/Proxy Form 9 Oct 2026 1:31PM $0.042 $0.032 fallen by 22.89%
$18 Dr John Le Gall appointed Chief Medical Officer 7 Oct 2026 9:18AM $0.041 $0.032 fallen by 21.95%
$18 azer-cel BTKi Cohort Reports new Complete & Partial Response 5 Oct 2026 8:56AM $0.037 $0.032 fallen by 13.51%
$18 Change of Director's Interest Notice - JD 1 Oct 2026 5:09PM $0.039 $0.032 fallen by 17.95%
$18 Application for quotation of securities - IMU 8 Sep 2026 4:07PM $0.066 $0.032 fallen by 51.52%
$18 Cleansing Notice 1 Sep 2026 4:43PM $0.068 $0.032 fallen by 52.94%
$18 Application for quotation of securities - IMU 1 Sep 2026 4:39PM $0.068 $0.032 fallen by 52.94%
$18 Change of Director's Interest Notice x4 1 Sep 2026 4:35PM $0.068 $0.032 fallen by 52.94%
$18 Corporate Governance Statement and Appendix 4G 28 Aug 2026 5:47PM $0.070 $0.032 fallen by 54.29%
$18 Appendix 4E and Annual Report 28 Aug 2026 5:28PM $0.070 $0.032 fallen by 54.29%

1 - 25 of 1219 results

Page 1 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.